Max Topp

Max Topp is head of haematology and associate Professor for translational immunology at the medical clinic II at the Universitätsklinikum Würzburg, Germany. After completing his medical degree at the University of Berlin, Germany, he undertook residencies at the Free University of Berlin and the University of Tübingen, both in Germany, and a postdoctoral fellowship in immunotherapy at the Fred Hutchinson Cancer Research Center in Seattle, USA. He is board certified in Internal medicine and haematology/oncology was appointed as associated professor for translational immunology in 2011 and head of haematology in 2014 at the Universitätsklinikum Würzburg. Professor Topp’s research interests are in immunotherapy both by with bispecific antibody constructs and CAR-T cells of leukaemia and lymphomas. In addition, he has been the principal investigator in numerous trials for acute lymphoblastic leukaemia, Hodgkin’s lymphoma and diffuse large B-cell lymphoma. He is also a steering committee member of the German ALL Study Group and German Hodgkin Lymphoma Study Group.